News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,192 Results
Type
Article (42256)
Company Profile (436)
Press Release (670500)
Multimedia
Podcasts (76)
Webinars (13)
Section
Business (208711)
Career Advice (2021)
Deals (36003)
Drug Delivery (104)
Drug Development (83566)
Employer Resources (173)
FDA (16421)
Job Trends (15091)
News (352742)
Policy (33070)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2642)
Accelerated approval (6)
Adcomms (24)
Allergies (84)
Alliances (50930)
ALS (92)
Alzheimer's disease (1420)
Antibody-drug conjugate (ADC) (127)
Approvals (16409)
Artificial intelligence (257)
Autoimmune disease (24)
Automation (15)
Bankruptcy (372)
Best Places to Work (11841)
BIOSECURE Act (18)
Biosimilars (105)
Biotechnology (330)
Bladder cancer (65)
Brain cancer (26)
Breast cancer (270)
Cancer (2143)
Cardiovascular disease (179)
Career advice (1687)
Career pathing (29)
CAR-T (150)
Cell therapy (426)
Cervical cancer (19)
Clinical research (67635)
Collaboration (838)
Compensation (516)
Complete response letters (24)
COVID-19 (2642)
CRISPR (42)
C-suite (235)
Cystic fibrosis (105)
Data (2083)
Decentralized trials (2)
Denatured (27)
Depression (47)
Diabetes (261)
Diagnostics (6408)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (105)
Drug shortages (26)
Duchenne muscular dystrophy (98)
Earnings (87579)
Editorial (39)
Employer branding (21)
Employer resources (147)
Events (115449)
Executive appointments (712)
FDA (17627)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (754)
Gene editing (109)
Generative AI (20)
Gene therapy (312)
GLP-1 (737)
Government (4493)
Grass and pollen (4)
Guidances (51)
Healthcare (19143)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (27)
Infectious disease (2785)
Inflammatory bowel disease (140)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (92)
Interviews (311)
IPO (16776)
IRA (43)
Job creations (3699)
Job search strategy (1434)
Kidney cancer (9)
Labor market (36)
Layoffs (489)
Leadership (17)
Legal (7982)
Liver cancer (73)
Lung cancer (309)
Lymphoma (141)
Machine learning (5)
Management (58)
Manufacturing (291)
MASH (65)
Medical device (13496)
Medtech (13501)
Mergers & acquisitions (19738)
Metabolic disorders (691)
Multiple sclerosis (77)
NASH (19)
Neurodegenerative disease (97)
Neuropsychiatric disorders (30)
Neuroscience (1964)
NextGen: Class of 2025 (6755)
Non-profit (4546)
Northern California (2566)
Now hiring (38)
Obesity (376)
Opinion (222)
Ovarian cancer (75)
Pain (84)
Pancreatic cancer (81)
Parkinson's disease (153)
Partnered (21)
Patents (225)
Patient recruitment (100)
Peanut (47)
People (58594)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21250)
Phase II (29842)
Phase III (22072)
Pipeline (1140)
Policy (138)
Postmarket research (2601)
Preclinical (9069)
Press Release (67)
Prostate cancer (101)
Psychedelics (37)
Radiopharmaceuticals (261)
Rare diseases (396)
Real estate (6014)
Recruiting (66)
Regulatory (22668)
Reports (46)
Research institute (2415)
Resumes & cover letters (351)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (73)
Series A (134)
Series B (87)
Service/supplier (11)
Sickle cell disease (57)
Southern California (2220)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (29)
Startups (3758)
State (2)
Stomach cancer (14)
Supply chain (66)
Tariffs (24)
The Weekly (47)
United States (22600)
Vaccines (688)
Venture capitalists (40)
Weight loss (250)
Women's health (36)
Worklife (16)
Date
Today (31)
Last 7 days (491)
Last 30 days (2427)
Last 365 days (33871)
2025 (9475)
2024 (36301)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (736)
Alabama (57)
Alaska (7)
Arizona (237)
Arkansas (14)
Asia (39170)
Australia (6524)
California (5915)
Canada (1952)
China (500)
Colorado (260)
Connecticut (275)
Delaware (137)
Europe (85582)
Florida (864)
Georgia (203)
Idaho (57)
Illinois (532)
India (25)
Indiana (304)
Iowa (10)
Japan (151)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (877)
Massachusetts (4514)
Michigan (217)
Minnesota (384)
Mississippi (2)
Missouri (79)
Montana (29)
Nebraska (25)
Nevada (60)
New Hampshire (66)
New Jersey (1693)
New Mexico (30)
New York (1674)
North Carolina (1003)
North Dakota (7)
Northern California (2566)
Ohio (197)
Oklahoma (14)
Oregon (37)
Pennsylvania (1321)
Puerto Rico (11)
Rhode Island (31)
South America (1110)
South Carolina (20)
South Dakota (1)
Southern California (2220)
Tennessee (99)
Texas (880)
Utah (174)
Virginia (140)
Washington D.C. (61)
Washington State (552)
West Virginia (3)
Wisconsin (52)
713,192 Results for "cytomx therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
CytomX to Cut 40% of Staff as It Updates Pipeline Priorities
CytomX’s workforce cuts could leave the biotech with fewer than 75 employees as it focuses resources on its wholly owned clinical-stage programs, most notably an antibody-drug conjugate for advanced metastatic colorectal cancer.
January 7, 2025
·
1 min read
·
Angela Gabriel
Press Releases
CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update
March 6, 2025
·
12 min read
Press Releases
CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference
March 5, 2025
·
2 min read
Press Releases
CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
February 27, 2025
·
2 min read
Business
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024.
June 17, 2024
·
6 min read
Biotech Bay
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
CytomX Therapeutics, Inc. today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 8:30 a.m. ET.
May 22, 2024
·
2 min read
Press Releases
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
January 7, 2025
·
10 min read
Press Releases
CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
2 min read
Business
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
CytomX Therapeutics, Inc., a leader in the field of masked, conditionally activated biologics, reported first quarter 2024 financial results and provided a business update.
May 8, 2024
·
15 min read
Biotech Bay
CytomX Therapeutics to Present at Upcoming March Investor Conferences
CytomX Therapeutics, Inc. today announced that management will participate in the following investor conferences in March.
February 27, 2024
·
2 min read
1 of 71,320
Next
